1[2]KIECHL S, LORENZ E, REINDL M, et al. Toll-like receptor 4 polymorphisms and atherogenesis[J]. N Engl J Med, 2002,347(3): 185-191.
2[3]AKIRA S, HEMMI H. Recognition of pathogen-associated molecular patterns by TLR family[J]. Immunol Lett, 2003,85(2):85-95.
3[4]HWANG D. Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through Toll-like receptor 4-derived signaling pathways[J]. FASEB J, 2001, 15(14): 2556-2564.
4[5]ABEL B, THIEBLEMONT N, QUESNIAUX VT, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice[J]. J Immunol, 2002, 169(6):3155-3162.
5[6]ISHII K, TAKAMURA N, SHINOHARA E,et al. Intracellular cytokine analysis of CD4-positive T cells predictive of sustained response to interferon therapy for patients with chronic hepatitis C[J]. Dig Dis Sci, 2002, 47(4):778-783.
6[7]LORENZ E, MIRA JP, FREES KL, et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock[J]. Arch Intern Med, 2002, 162(9):1028-1032.
7[8]BEG AA. Endogenous ligands of Toll-like receptors :implications for regulating inflammatory and immune responses[J]. Trends Immunol, 2002, 23(11):509-512.
8[9]KOBAYASHI N, TAKESUE M, KOBAYASHI M, et al. Evaluation of toll-like receptor 4 gene expression of immortalized human liver cell lines[J]. Transplant Proc, 2003, 35(1):431-432.
9[10]DOYLE SE, O'CONNELL R, VAIDYA SA, et al. Toll-like receptor 3 mediates a more potent antiviral response than toll-like receptor 4[J]. J Immunol,2003,170(7):3565-3571.
10[11]KADOWAKI N, LIU YJ. Natural type I interferon-producing cells as a link between innate and adaptive immunity[J]. Hum Immunol, 2002,63(12):1126-1132.
